The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
Open accessAbstract
Background and aims No drugs are currently approved for Coronavirus Disease-2019 (COVID-19), although some have been tried. In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and COVID-19, adverse effects related to drugs, and related guidelines. Aims and methods We systematically searched the PubMed database up till March 21, 2020 and retrieved all the articles published on chloroquine and HCQ and COVID-19. Results Two small human studies have been conducted with both these drugs in COVID-19, and have shown significant improvement in some parameters in patients with COVID-19. Conclusion Considering minimal risk upon use, a long experience of use in other diseases, cost-effectiveness and easy availability across India, we propose that both these drugs are worthy of fast track clinical trial for treatment, and may be carefully considered for clinical use as experimental drugs. Since HCQ has been approved for treatment of diabetes in India, it should be further researched in diabetes and COVID-19, a subgroup where significant mortality has been shown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Melles, R. B., & Mieler, W. F. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.058 · Cited by 1,164
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.03.005 · Cited by 1,160
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Lu, H. (2020) · BioScience Trends · doi:10.5582/bst.2020.01020 · Cited by 1,133
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937 · cited 2×
“It is believed that both the agents could be effective tools against SARSCoV-1 and SARS-CoV-2 [10,11].”
Lai, C.-C., Liu, Y. H., Wang, C.-Y., Wang, Y.-H., Hsueh, S.-C., Yen, M.-Y., Ko, W.-C., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.02.012 · Cited by 935
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Touret, F., & de Lamballerie, X. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104762 · Cited by 541
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
Gupta, R., Ghosh, A., Singh, A. K., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.002 · Cited by 518
Self-citationChloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J.-M., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 468
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
Tricou, V., Minh, N. N., Van, T. P., Lee, S. J., Farrar, J., Wills, B., Tran, H. T., & Simmons, C. P. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000785 · Cited by 329
Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities
Biot, C., Daher, W., Chavain, N., Fandeur, T., Khalife, J., Dive, D., & De Clercq, E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601856 · Cited by 320
Zhou, N., Pan, T., Zhang, J., Li, Q., Zhang, X., Bai, C., Huang, F., Peng, T., Zhang, J., Liu, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716100 · Cited by 286
Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial
Paton, N. I., Lee, L., Xu, Y., Ooi, E. E., Cheung, Y. B., Archuleta, S., Wong, G., & Smith, A. W. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70065-2 · Cited by 189
Antibiotic Susceptibility of Tropheryma whipplei in MRC5 Cells
Boulos, A., Rolain, J., & Raoult, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.747-752.2004 · Cited by 152
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
Roques, P., Thiberville, S.-D., Dupuis-Maguiraga, L., Lum, F., Labadie, K., Martinon, F., Gras, G. S., Lebon, P., Ng, L. F. P., de Lamballerie, X. N., et al. (2018) · Viruses · doi:10.3390/v10050268 · Cited by 149
Raoult, D., Drancourt, M., & Vestris, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1512 · Cited by 127
Liu, D., Li, X., Zhang, Y., Kwong, J. S. W., Li, L., Zhang, Y., Xu, C., Li, Q., Sun, X., Tian, H., et al. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s166893 · Cited by 120
Helal, G. K., Gad, M., Abd‐Ellah, M. F., & Eid, M. S. (2016) · Journal of Medical Virology · doi:10.1002/jmv.24575 · Cited by 43
The enigma of the clandestine association between chloroquine and HIV ‐1 infection
Chauhan, A., & Tikoo, A. (2015) · HIV Medicine · doi:10.1111/hiv.12295 · Cited by 36
Seth, P., Mani, H., Singh, A., Banaudha, K. K., Madhavan, S., Sidhu, G. S., Gaddipati, J. P., Vogel, S. N., & Maheshwari, R. K. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.180 · Cited by 24
Self-citation
Cited by
A comprehensive review of COVID-19 characteristics
Esakandari, H., Nabi-Afjadi, M., Fakkari-Afjadi, J., Farahmandian, N., Miresmaeili, S.-M., & Bahreini, E. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00128-2 · Cited by 510
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19
Rosenthal, N., Cao, Z., Gundrum, J., Sianis, J., & Safo, S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29058 · Cited by 484
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Elengoe, A. (2020) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2020.11.3.08 · Cited by 307
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
Pal, R., & Bhadada, S. K. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.049 · Cited by 299
Metadata
- Authors
- Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 14
- Issue
- 3
- Pages
- 241-246
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W3012899771
- Cited by
- 488
- References
- 27
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.